SEC Form 4 · accession 0001628280-26-054338
CASTLE BIOSCIENCES INC · CSTL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tobin W Juvenal
Officer — Chief Commercial Officer
Period of report
Nov 24, 2025
Accepted (ET)
Aug 6, 2026 · 4:14 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001447362
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 24, 2025 | S | 1,301 | $38.39 | D | 77,694 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 11, 2024.